Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Viral Vectors and Plasmid DNA Manufacturing Market to reach USD 7.35 Billion by 2027.

Global Viral Vectors And Plasmid DNA Manufacturing Market Size study, by Vector type (Adenovirus, Retrovirus, Adeno-associated Virus (AAV), Lentivirus, Plasmid DNA, Others), by End-use (Pharmaceutical and Biopharmaceutical Companies, Research Institutes), by Application (Antisense & RNAi Therapy, Gene Therapy, Vaccinology, Research Applications), and Regional Forecasts 2021-2027

Product Code: HLSHS-56593879
Publish Date: 12-10-2021
Page: 200

Global Viral Vectors and Plasmid DNA Manufacturing Market is valued approximately at USD 2.2 Billion in 2020 and is anticipated to grow with a healthy growth rate of more than 18.8% over the forecast period 2021-2027. The global viral vectors and plasmid DNA manufacturing market is being driven by growth in funding for R&D activities pertaining to gene therapy, growth in prevalence of cancer, viral infections, and genetic disorders as well as increase in awareness regarding gene therapies. Furthermore, increase in demand for synthetic genes, will provide new opportunities for the global viral vectors and plasmid DNA manufacturing industry. For instance, according to national cancer institutes in year 2018, there were around 18.1 million new cases and 9.5 million cancer-related deaths across the world. By 2040, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. As a result, increased in prevalence of cancer cases will necessitate the use of viral vectors and plasmid DNA manufacturing will serve as a catalyst for the viral vectors and plasmid DNA Manufacturing industry in the future. However, high cost associated with gene therapies, risk of mutagenesis and other impediments in gene therapy may impede market growth over the forecast period of 2021-2027.

Asia Pacific, North America, Europe, Latin America, and Rest of the World are the key region considered for the regional analysis of viral vectors and plasmid DNA manufacturing. The presence of a substantial number of centers and institutes that are engaged in the R&D of advanced therapies and increase in regulatory approvals makes the North America the the leading region across the world in terms of market share. Whereas North America is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due growing private and government investments, and increasing healthcare needs in the region.
Major market player included in this report are:

Merck KGaA
Lonza.
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
Cobra biologics ltd.
Thermo fisher scientific inc.
Waisman Biomanufacturing
Genezen laboratories
YPOSKESI
Advanced BioScience Laboratories, Inc. (ABL inc.)
Novasep holding s.a.s.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Vector Type:
Adenovirus
Retrovirus
Adeno-associated Virus (AAV)
Lentivirus
Plasmid DNA
Others
By End-use:
Pharmaceutical and Biopharmaceutical Companies
Research Institutes
By Application:
Antisense & RNAi Therapy
Gene Therapy
Vaccinology
Research Applications

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Viral Vectors And Plasmid DNA Manufacturing Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Viral Vectors And Plasmid DNA Manufacturing Market , by Region, 2019-2027 (USD Billion)
1.2.2. Viral Vectors And Plasmid DNA Manufacturing Market , by Vector Type, 2019-2027 (USD Billion)
1.2.3. Viral Vectors And Plasmid DNA Manufacturing Market , by End Use, 2019-2027 (USD Billion)
1.2.4. Viral Vectors And Plasmid DNA Manufacturing Market , by Application, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Viral Vectors And Plasmid DNA Manufacturing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Viral Vectors And Plasmid DNA Manufacturing Market Dynamics
3.1. Viral Vectors And Plasmid DNA Manufacturing Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increase in funding for R&D activities pertaining to gene therapy
3.1.1.2. Rise in prevalence of cancer, viral infections, and genetic disorders
3.1.1.3. Increase in awareness regarding gene therapies
3.1.2. Market Restraint
3.1.2.1. High cost associated with gene therapies
3.1.2.2. Risk of mutagenesis and other impediments in gene therapy
3.1.3. Market Opportunities
3.1.3.1. Increase in demand for synthetic genes
Chapter 4. Global Viral Vectors And Plasmid DNA Manufacturing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Viral Vectors And Plasmid DNA Manufacturing Market , by Vector Type
5.1. Market Snapshot
5.2. Global Viral Vectors And Plasmid DNA Manufacturing Market by Vector Type, Performance – Potential Analysis
5.3. Global Viral Vectors And Plasmid DNA Manufacturing Market Estimates & Forecasts by Vector Type 2018-2027 (USD Billion)
5.4. Viral Vectors And Plasmid DNA Manufacturing Market , Sub Segment Analysis
5.4.1. Adenovirus
5.4.2. Retrovirus
5.4.3. Adeno-associated Virus (AAV)
5.4.4. Lentivirus
5.4.5. Plasmid DNA
5.4.6. Others
Chapter 6. Global Viral Vectors And Plasmid DNA Manufacturing Market , by End Use
a. Market Snapshot
6.1. Global Viral Vectors And Plasmid DNA Manufacturing Market by End Use, Performance – Potential Analysis
6.2. Global Viral Vectors And Plasmid DNA Manufacturing Market Estimates & Forecasts by End Use2018-2027 (USD Billion)
6.3. Viral Vectors And Plasmid DNA Manufacturing Market , Sub Segment Analysis
6.3.1. Pharmaceutical and Biopharmaceutical Companies
6.3.2. Research Institutes
Chapter 7. Global Viral Vectors And Plasmid DNA Manufacturing Market , by Application
b. Market Snapshot
7.1. Global Viral Vectors And Plasmid DNA Manufacturing Market by Application, Performance – Potential Analysis
7.2. Global Viral Vectors And Plasmid DNA Manufacturing Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
7.3. Viral Vectors And Plasmid DNA Manufacturing Market , Sub Segment Analysis
7.3.1. Antisense & RNAi Therapy
7.3.2. Gene Therapy
7.3.3. Vaccinology
7.3.4. Research Applications
Chapter 8. Global Viral Vectors And Plasmid DNA Manufacturing Market , Regional Analysis
8.1. Viral Vectors And Plasmid DNA Manufacturing Market , Regional Market Snapshot
8.2. North America Viral Vectors And Plasmid DNA Manufacturing Market
8.2.1. U.S. Viral Vectors And Plasmid DNA Manufacturing Market
8.2.1.1. Vector Type breakdown estimates & forecasts, 2018-2027
8.2.1.2. End Use breakdown estimates & forecasts, 2018-2027
8.2.1.3. Application breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Viral Vectors And Plasmid DNA Manufacturing Market
8.3. Europe Viral Vectors And Plasmid DNA Manufacturing Market Snapshot
8.3.1. U.K. Viral Vectors And Plasmid DNA Manufacturing Market
8.3.2. Germany Viral Vectors And Plasmid DNA Manufacturing Market
8.3.3. France Viral Vectors And Plasmid DNA Manufacturing Market
8.3.4. Spain Viral Vectors And Plasmid DNA Manufacturing Market
8.3.5. Italy Viral Vectors And Plasmid DNA Manufacturing Market
8.3.6. Rest of Europe Viral Vectors And Plasmid DNA Manufacturing Market
8.4. Asia-Pacific Viral Vectors And Plasmid DNA Manufacturing Market Snapshot
8.4.1. China Viral Vectors And Plasmid DNA Manufacturing Market
8.4.2. India Viral Vectors And Plasmid DNA Manufacturing Market
8.4.3. Japan Viral Vectors And Plasmid DNA Manufacturing Market
8.4.4. Australia Viral Vectors And Plasmid DNA Manufacturing Market
8.4.5. South Korea Viral Vectors And Plasmid DNA Manufacturing Market
8.4.6. Rest of Asia Pacific Viral Vectors And Plasmid DNA Manufacturing Market
8.5. Latin America Viral Vectors And Plasmid DNA Manufacturing Market Snapshot
8.5.1. Brazil Viral Vectors And Plasmid DNA Manufacturing Market
8.5.2. Mexico Viral Vectors And Plasmid DNA Manufacturing Market
8.6. Rest of The World Viral Vectors And Plasmid DNA Manufacturing Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Merck KGaA
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Lonza.
9.2.3. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
9.2.4. Cobra biologics ltd.
9.2.5. Thermo fisher scientific inc.
9.2.6. Waisman Biomanufacturing
9.2.7. Genezen laboratories
9.2.8. YPOSKESI
9.2.9. Advanced BioScience Laboratories, Inc. (ABL inc.)
9.2.10. Novasep holding s.a.s.

Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now